Four years back, Adnan Asar, the creator of the new dependency prevention service Lucid Lane, was taking pleasure in a successful career working as the founding chief innovation officer at Livongo Health. It was the serial senior tech executive’s latest job after a long stint at Shutterfly and he was shepherding the business through the advancement of its suite of hardware and software for the management of chronic conditions.
When Asar’s spouse was detected with non-Hodgkin’s Lymphoma, he stepped away from the technology world to be with his family while she went through treatment.
He did not know at the time that the choice would set him on the path to founding Lucid Lane. The business’s mission is to help give clients who have been recommended medications to attend to discomfort and anxiety ways to wean themselves off those drugs and avoid dependency– and its function is born from the battle Asar experienced as his partner battled with how to stop taking the medication she was prescribed during her health problem.
Asar’s spouse isn’t alone. In 2018, there were approximately 168.2 million prescriptions for opioids written in the United States, according to data from the Centers for Illness Control and Prevention. Lucid Lane approximates that 50 million individuals are prescribed opioids and another 13 million are prescribed benzodiazepines each year either after surgery or in conjunction with cancer treatments– all without a plan for how to taper the use or handle of these extremely addictive medications.
For Asar’s spouse, it was the benzodiazepine prescribed as part of her cancer treatment that became an issue. “She was hit by very extreme withdrawal signs and we didn’t know what was going on,” Asar said. When they consulted her doctor he provided the couple 2 alternatives– giving up cold turkey or staying on the medication.
“My better half decided to go cold turkey,” Asar stated. “It was really crippling for the entire household.”
It took nine months of treatment and regular assessments with psychiatrists to aid with customizing medication does and tapering to get her off of the medication, said Asar. Which experience led to the launch of Lucid Lane.
“Our objective is to prevent and manage medication and substance reliance,” Asar said.
The business’s telehealth solution is built on a proprietary treatment procedure suggested to provide constant everyday assistance and interventions, along with proactive monitoring of a customized treatment strategy– all on a continuous basis, said Asar.
And the COVID-19 pandemic is only speeding up the requirement for telehealth services. “COVID-19 has made telehealth a necessary service instead of a discretionary service,” stated Asar. “There’s a rise in anxiety, depression, compound usage and medication usage. We’re seeing a rise of clients who are connecting to us.”
Asar sees Lucid Lane’s rivals as business like Lyra Health and Ginger, or point services constructing digital diagnostics to spot stress and anxiety and anxiety. However unlike some business that are releasing to treat dependency or addicting behaviors, Asar sees his startup as avoiding reliance and addiction.
“A great deal of people are moving into these addictions through something that occurs at the physician’s office,” said Asar. “ Our service does not prescribe any of these medications.”
The company is dealing with clinical studies that are set to start at the Palo Alto VA hospital, and has actually raised $4 million in seed financing from financiers consisting of Battery Ventures and AME Cloud Ventures, the investment company established by Jerry Yang.
“We see excellent prospective for Lucid Lane, as it has actually developed a scalable option to one of the most significant issues facing society today,” stated Battery general partner Dharmesh Thakker, in a statement.”Telehealth solutions have actually become highly capable of attending to complex issues, and Lucid Lane has welcomed remote care from its beginning. Its design enables care anytime, anywhere for clients in their moment of requirement. This can make a tremendous distinction in the battle in between healing and relapse. Our company believe that it will assist millions of people lead better lives.”
Signing up with Asar in the development of the business and its healthcare protocols are a skilled group of health experts, including Dr. Ahmed Zaafran, a board licensed anesthesiologist at Santa Clara Valley Medical Center and assistant professor of anesthesiology (associated) at Stanford University School of Medicine; and consultants like Dr. Vanila Singh, who was also previously chairperson of the HHS Task Force in combination with the DOD and the VA to deal with the opioid drug crisis; Dr. Carin Hagberg, the chair of perioperative, anesthesiology and pain medicine of MD Anderson Cancer Center; and Sherif Zaafran, the president of the Texas Medical Board and chair of several nationwide committees on discomfort management, consisting of the subcommittee Taskforce on Pain Management Services for HHS, as well as the department’s Discomfort Clinical Pathways Committee.
“Lucid Lane offers a patient-centered service that allows for the very best scientific results for clients after surgery and those fearlessly completing chemotherapy,” said Dr. Singh, in a statement. “For the numerous patients who need short-term opioids and benzodiazepine medications, Lucid Lane’s treatment can limit the danger of prolonged dependence of these medications while likewise making sure effective pain control with a resulting improved quality of life and working.”
Article curated by RJ Shara from Source. RJ Shara is a Bay Area Radio Host (Radio Jockey) who talks about the startup ecosystem – entrepreneurs, investments, policies and more on her show The Silicon Dreams. The show streams on Radio Zindagi 1170AM on Mondays from 3.30 PM to 4 PM.